Drug Type Small molecule drug |
Synonyms A 56619, A-56619 |
Target |
Action inhibitors |
Mechanism Bacterial DNA gyrase inhibitors(Bacterial DNA gyrase inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H19F2N3O3 |
InChIKeyNOCJXYPHIIZEHN-UHFFFAOYSA-N |
CAS Registry98106-17-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Difloxacin | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bacterial Infections | Preclinical | United States | 01 Nov 1985 | |
Gram-Negative Bacterial Infections | Preclinical | United States | 17 Jul 1985 | |
Gram-Negative Bacterial Infections | Preclinical | United States | 17 Jul 1985 | |
Gram-Positive Bacterial Infections | Preclinical | United States | 17 Jul 1985 | |
Gram-Positive Bacterial Infections | Preclinical | United States | 17 Jul 1985 |